Clinical Trials Logo

Pituitary Neoplasms clinical trials

View clinical trials related to Pituitary Neoplasms.

Filter by:

NCT ID: NCT06326853 Not yet recruiting - Acromegaly Clinical Trials

Neuroendocrine Mechanisms in Adiposity: An Integrated Approach to the Characterization of Potential Pharmacological Novel Targets Based on Experimental and Clinical Models

Start date: July 2024
Phase:
Study type: Observational

The goal of this observational study is to evaluate, retrospectively and prospectively, the effect of different hormonal and neuropeptide dysfunctions on the body composition of patients suffering from hypothalamic-pituitary pathologies, and to evaluate the potential beneficial effect of surgical and medical treatments with agonists and antagonists of hypothalamic neuropeptides, currently available, on the development and treatment of adiposity and negative cross-talk between adiposity and muscle/bone tissue

NCT ID: NCT06297473 Not yet recruiting - Clinical trials for Non-Functional Pituitary Adenoma

Physical Attendance Versus Telephone or Video Follow-up in Patients With Non-functioning Pituitary Tumors.

PITCARE
Start date: April 1, 2024
Phase: N/A
Study type: Interventional

The primary purpose of this study is to compare the safety of routine telephone assessment versus in-person assessment during a two-year period for patients with non-functioning pituitary adenomas. Secondly, to compare the quality of pituitary care in persons having biochemical assessment once versus twice a year. Thirdly, to assess the rationale of repeated assessment of pituitary function and imaging in patients with small pituitary tumors (microadenomas).

NCT ID: NCT06295952 Recruiting - Clinical trials for Prolactin-Producing Pituitary Tumor

A Study of Pasireotide in People With Prolactinoma

Start date: February 27, 2024
Phase: Phase 2
Study type: Interventional

The researchers are doing this study to find out whether pasireotide is an effective treatment for people with prolactinoma who cannot receive dopamine agonist therapy. Another purpose of this study is to find out whether pasireotide is a safe treatment for people with prolactinoma.

NCT ID: NCT06282224 Not yet recruiting - Pituitary Neoplasms Clinical Trials

Application of Augmented Reality Neuronavigation in Transnasal Endoscopic Skull Base Surgery

Start date: March 11, 2024
Phase: N/A
Study type: Interventional

"For lesions in the skull base, including meningiomas, chordomas and pituitary tumors, endoscopic surgery has replaced traditional microscopes as the mainstream procedure. Although neurosurgeons can enlarge the surgical area using a neuroendoscope, it does not provide any information on the morphology and location of anatomical structures beneath visible surfaces. Due to the complex anatomical relationships of adjacent structures in the skull base, lesions occurring here are often located deep within anatomy that is difficult to fully expose and remove with endoscopic surgery alone. Especially when dealing with larger tumors that surround major arteries and nerves, limited visibility at surface level can easily damage blood vessels or nerves causing complications such as bleeding during or after surgery, deformities or functional impairments. The purpose of this study is to explore how augmented reality (AR) technology can highlight important anatomical structures in a neuroendoscope's field of view to optimize surgical visibility beyond what is possible with just an endoscope alone. This will make it easier for surgeons to distinguish deeper anatomical structures and reduce intraoperative and postoperative complications associated with endoscopic surgery."

NCT ID: NCT06266949 Not yet recruiting - Pituitary Tumor Clinical Trials

Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors

Start date: August 1, 2024
Phase:
Study type: Observational

The purpose of this study is to assess wether the SONDA visual field test is suitable for patients with a supra sellar tumour.

NCT ID: NCT06234553 Active, not recruiting - Pituitary Adenoma Clinical Trials

Application of Radiomics in the Diagnosis and Treatment Prediction of Pituitary Adenoma

RIPA
Start date: January 1, 2022
Phase:
Study type: Observational

The images of patients with Pituitary adenoma were collected and analyzed based on the methods of radiomics.

NCT ID: NCT06221020 Recruiting - Clinical trials for Postoperative Complications

To Assess the Impact of theERAS Consensus on Patients With Endoscopic Pituitary Tumor Surgery

Start date: December 12, 2023
Phase:
Study type: Observational [Patient Registry]

The goal of this observational study is to evaluate the effectiveness and impact of Enhanced Recovery After Surgery (ERAS) on patients with pituitary gland tumors.

NCT ID: NCT06163261 Recruiting - Clinical trials for Non-functioning Pituitary Adenoma

Individualized Physical Activity or Patients With Non Functioning Pituitary Adenoma

Start date: February 27, 2024
Phase: N/A
Study type: Interventional

The goal of this clinical trial is to learn about physical activity's effect on health in people who have had surgery of a non-functioning pituitary adenoma. The main questions it aims to answer are: - Do physical activity increase quality of life? - Do physical activity increase general health, cardiovascular fitness, self-efficacy and muscle strength and reduce fatigue and cardiovascular risk profile? Participants will at the start of the the study, at 6 months follow up and 12 months follow up: - Fill out health surveys - Perform a cycling test, hand strength test, chair stand test and wear and accelerometer for a week - Undergo a dual energy X-ray absorptiometry to measure muscle and fat mass - Leave blood samples Researchers will compare those who are randomized to the intervention and see a physiotherapist to get an individualized and person-centred prescription of physical activity plan and those who are randomized not to be in the intervention to see if physical activity increases quality of life and general health.¨.

NCT ID: NCT06156020 Recruiting - Pituitary Adenoma Clinical Trials

Outcome Analysis of Endoscopic Resection of Pituitary Adenomas

Start date: January 1, 2020
Phase: N/A
Study type: Interventional

The goal of this prospective study is to learn about the operative outcomes in patients with pituitary adenoma who receive endoscopic resection. The main question it aims to answer is: • What are the outcomes of patient following endoscopic resection? including visual, hormonal, survival, and functional outcomes. Participants' data including clinical history, laboratory data, radiographic images, intraoperative videos will be evaluated and analyzed.

NCT ID: NCT06053437 Completed - Pituitary Adenoma Clinical Trials

Prognostic Indicators in Pituitary Adenoma Surgery: a Comprehensive Analysis of Surgical Outcomes and Complications.

Hyp'Op
Start date: February 1, 2023
Phase:
Study type: Observational

Predicting the outcome of pituitary surgery, particularly the risk of complications, is a critical determinant in selecting the appropriate treatment modality for patients. To date, only a limited number of risk factors have been identified for complications following pituitary surgery, including tumor size, younger age, and previous surgical intervention. Furthermore, existing studies have demonstrated that prolactin levels can serve as a surrogate marker for assessing pituitary function, specifically revealing associations between elevated prolactin levels and anterior pituitary insufficiencies. In a retrospective study on the "HYP'OP" cohort, the aim of the study is to identify predictive factors for both surgical outcomes and complications.